The global Cannabidiol (CBD) Pills and Capsules  market size is expected to reach USD 15.15 billion in 2028 and register a revenue CAGR of 22.6% over the forecast period, according to the latest report by Reports and Data. The most important factors driving market revenue growth are rising awareness about the medicinal uses of CBD and increasing government approvals for cannabidiol use in numerous consumer products. Increasing research & development activities related CBD, increasing incorporation of CBD in a wide range of food and beverage products, rising health consciousness among consumers, and growing demand for cannabis in the pharmaceutical and cosmetics & personal care industries are other major factors expected to support market growth during the forecast period.

Get a sample of the report @https://www.reportsanddata.com/sample-enquiry-form/1373 

Some Key Highlights from the Report:

• Based on product type, the oils segment is expected to hold the largest revenue share in the global cannabidiol (CBD) market over the forecast period, primarily owing to growing demand for CBD-based oils due to numerous advantages, most notably, pain relief. CBD-infused oils are known to relieve pain, inflammation, stress, and mental problems such as depression and anxiety. Increasing prevalence of chronic pain, mostly among the geriatric population, and growing preference for CBD oils over opioids due to minimal or no side-effects are other key factors boosting growth of this segment.
• Based on source, the hemp segment accounted for the highest revenue share of around 60% in the global market in 2020. Increasing pharmaceutical uses of cannabidiol, growing consumer awareness of the therapeutic benefits including anti-aging, anti-inflammatory, and antioxidant properties of hemp-derived CBD, legalization of medicinal cannabis, and growing use of CBD in nutraceuticals and cosmeceuticals are major factors propelling the growth of this segment.
• The medical segment is expected to dominate other application segments in the market in terms revenue generation over the forecast period. Growth of this segment is majorly attributed to increasing research studies on the medicinal uses of CBD, growing use in pain relief medications, rising awareness about the medical benefits of cannabidiol, and increased spending on CBD pharmaceutical products.
• North America was the most dominant regional market in the global cannabidiol (CBD) market in 2020, with the highest revenue share of over 40%. Increasing personal and medical uses of marijuana and its derivatives in the region, growing awareness about the health benefits of cannabis, increasing public acceptance of CBD, and legalization of cannabidiol and its use in various consumer products including food & beverages and nutraceuticals are key factors contributing to the North America revenue growth. Moreover, revenue growth in the regional market is further driven by the presence of leading pharmaceutical retailers – mostly in the U.S., including CVS Health, Walgreens, and Rite Aid – selling a wide array of cannabis-based products.

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1373 

Key companies profiled :

• Folium Biosciences LLC
• Elixinol Wellness Limited
• MedterraCV Sciences, Inc.
• Aurora Cannabis Inc.
• Medical Marijuana Inc.
• Isodiol International Inc.
• Cannoid, LLC
• PharmaHemp d.o.o.
• ENDOCA.

For this study, Reports and Data has segmented the global Cannabidiol (CBD) market based on product, source, application, distribution channel, and region:  

By Product Outlook

• Tinctures

• Transdermal Patches

• Pills & Capsules

• Isolates

• Suppository

• Oil

• Vape Oil

• Ointment Roll On

• Others

By Source Outlook :

• Hemp

• Marijuana

By Application Outlook 

• Personal Use

• Medical

  • Cancer

  • Chronic Pain

  • Mental Disorders

  • Others

• Food & Beverages

• Cosmetics & Personal Care

• Nutraceuticals

• What is the growth rate of the Cannabidiol (CBD) Market? What is the market size the Cannabidiol (CBD) Market is expected to reach by 2028?
• What are the key growth driving and restraining factors of the Cannabidiol (CBD) Market?
• Who are the prominent players operating in the market? What are the key strategies adopted by these companies?
• What are key opportunities and growth prospects of the Cannabidiol (CBD) Market over the forecast period?
• Which region is expected to show significant growth in the coming years?
• Which application segment is expected to be the most lucrative over the forecast period?

Thank you for reading our report. Please connect with us to know more about the report or for requesting customization of the report. Our team will ensure the report is best suited to meet your requirements.

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W, Head of Business Development

Reports And Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

LinkedIn | Twitter | Blogs

Read the innovative blog at   https://www.reportsanddata.com/blogs 
Check out our upcoming research report at https://www.reportsanddata.com/upcoming-reports